Cargando…
Microsurgical clipping as a retreatment strategy for previously ruptured aneurysms treated with the Woven EndoBridge (WEB) device: a mono-institutional case series
BACKGROUND: Since its approval by the US Food and Drug Administration (FDA) in 2018, the flow disruptor Woven EndoBridge (WEB) device has become increasingly popular for the endovascular treatment of unruptured and ruptured cerebral aneurysms. However, the occlusion rates seem rather low and the ret...
Autores principales: | Kranawetter, B., Hernández, S., Mielke, D., Ernst, M.S., Malinova, V., Rohde, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319653/ https://www.ncbi.nlm.nih.gov/pubmed/37178247 http://dx.doi.org/10.1007/s00701-023-05596-5 |
Ejemplares similares
-
Microsurgical clipping vs Woven EndoBridge (WEB) device for the management of unruptured wide-neck bifurcation aneurysms
por: Chacón-Quesada, Tatiana, et al.
Publicado: (2022) -
Woven EndoBridge embolization in the retreatment of basilar apex aneurysm
por: Lee, Jae Eun, et al.
Publicado: (2022) -
How to WEB: a practical review of methodology for the use of the Woven EndoBridge
por: Goyal, Nitin, et al.
Publicado: (2020) -
Treatment of recurrent aneurysms using the Woven EndoBridge (WEB): anatomical and clinical results
por: Gawlitza, Matthias, et al.
Publicado: (2018) -
Recurrent and Residual Aneurysms After Woven EndoBridge (WEB) Therapy: What’s Next?
por: Peterson, Catherine, et al.
Publicado: (2021)